Clinical trial
Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)
NCT00083980 · National Center for Complementary and Integrative Health (NCCIH), NIH · Terminated
Key facts
| NCT number | NCT00083980 |
|---|---|
| Title | Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD) |
| Official title | KAVA KAVA in Generalized Anxiety: A Double-Blind Trial |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anxiety Disorders |
| Intervention type | Drug |
| Interventions | Venlafaxine ER, Sugar pill, Kava |
| Enrollment | 16 |
| Start date | Jun 1, 2002 |
| Primary completion | Jun 1, 2004 |
| Completion | Aug 1, 2004 |
| First posted | Jun 7, 2004 |
| Last update posted | Oct 19, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: